within Pharmacolibrary.Drugs.J_AntiinfectivesForSystemicUse.J01E_SulfonamidesAndTrimethoprim.J01EE01_SulfamethoxazoleAndTrimethoprim;

model SulfamethoxazoleAndTrimethoprim
  extends Pharmacolibrary.Drugs.ATC.J.J01EE01;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>J01EE01</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Sulfamethoxazole and trimethoprim is a combination antibiotic used for the treatment of a variety of bacterial infections, including urinary tract infections, respiratory infections, and certain types of gastrointestinal infections. The combination is synergistic, targeting different steps of folic acid synthesis in bacteria, and is widely approved and used clinically today.</p><h4>Pharmacokinetics</h4><p>Typical pharmacokinetic parameters in healthy adults after oral administration of a standard dose of sulfamethoxazole 800 mg and trimethoprim 160 mg (co-trimoxazole).</p><h4>References</h4><ol><li><p>Punjabi, C, et al., &amp; Holubar, M (2019). Oral Fluoroquinolone or Trimethoprim-sulfamethoxazole vs. ß-lactams as Step-Down Therapy for Enterobacteriaceae Bacteremia: Systematic Review and Meta-analysis. <i>Open forum infectious diseases</i> 6(10) –. DOI:<a href=&quot;https://doi.org/10.1093/ofid/ofz364&quot;>10.1093/ofid/ofz364</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/31412127/&quot;>https://pubmed.ncbi.nlm.nih.gov/31412127</a></p></li><li><p>Petritz, OA, et al., &amp; Flammer, K (2023). Pharmacokinetics and Safety of Sulfamethoxazole-Trimethoprim After Oral Administration of Single and Multiple Doses to Rhode Island Red Chickens (. <i>Journal of avian medicine and surgery</i> 37(1) 1–12. DOI:<a href=&quot;https://doi.org/10.1647/22-00020&quot;>10.1647/22-00020</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/37358198/&quot;>https://pubmed.ncbi.nlm.nih.gov/37358198</a></p></li><li><p>Crump, JA, et al., &amp; Parry, CM (2015). Epidemiology, Clinical Presentation, Laboratory Diagnosis, Antimicrobial Resistance, and Antimicrobial Management of Invasive Salmonella Infections. <i>Clinical microbiology reviews</i> 28(4) 901–937. DOI:<a href=&quot;https://doi.org/10.1128/CMR.00002-15&quot;>10.1128/CMR.00002-15</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/26180063/&quot;>https://pubmed.ncbi.nlm.nih.gov/26180063</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end SulfamethoxazoleAndTrimethoprim;
